Accepted Paper:

Testosterone Enacted: Concerned Groups and Transgender Healthcare Policies  

Author:

Esther Ortega Arjonilla (Universidad Complutense de Madrid)

Paper short abstract:

In this paper, I will discuss different scenarios in which testosterone is enacted in relation to different spanish concerned groups and to recent transgender health policies in Spain.

Paper long abstract:

Between transgender health practices, hormones have been configured as very powerful political and cultural objects along the time. In Spain during the last decade, hormones have been configured as key players for legal recognition of sex change but also for the social sanction of sex and gender. In this sense, Spanish legislation requires two years of medical treatment, which is translated as (at least) hormonal treatment, to apply for legal recognition of sex and name changes in official documents.

Specifically a single hormone, testosterone, has been considered as a powerful technology among trans men, because in many cases testosterone allows them to be recognized as men in public space.

In this paper, I will discuss different scenarios in which testosterone is enacted in relation to different spanish concerned groups and in relation to recent transgender health policies in the Spanish state. These scenarios where testosterone is enacted allows me to analyze two key questions:

Firstly, the kind of involvement of some concerned groups in the decision-making process about transgender health.

Secondly, how the research of some activist groups have influenced present health policies about trans healthcare.

Panel T105
Wild research: Radical openings in technoscientific practice?